Xiaodong Guan

2.4k total citations
135 papers, 1.6k citations indexed

About

Xiaodong Guan is a scholar working on Economics and Econometrics, General Health Professions and Applied Microbiology and Biotechnology. According to data from OpenAlex, Xiaodong Guan has authored 135 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Economics and Econometrics, 23 papers in General Health Professions and 22 papers in Applied Microbiology and Biotechnology. Recurrent topics in Xiaodong Guan's work include Pharmaceutical Economics and Policy (33 papers), Health Systems, Economic Evaluations, Quality of Life (31 papers) and Antibiotic Use and Resistance (22 papers). Xiaodong Guan is often cited by papers focused on Pharmaceutical Economics and Policy (33 papers), Health Systems, Economic Evaluations, Quality of Life (31 papers) and Antibiotic Use and Resistance (22 papers). Xiaodong Guan collaborates with scholars based in China, United States and Hong Kong. Xiaodong Guan's co-authors include Donggen Wang, Luwen Shi, Haishaerjiang Wushouer, Tao Lin, Luwen Shi, Anita K. Wagner, Xinyu Cao, Yichen Zhang, Yue Zhou and Ye Tian and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaodong Guan

123 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodong Guan China 22 436 412 189 167 157 135 1.6k
Seyed Saeed Hashemi Nazari Iran 24 132 0.3× 69 0.2× 185 1.0× 40 0.2× 18 0.1× 169 2.0k
Ming Wu China 28 89 0.2× 186 0.5× 255 1.3× 120 0.7× 22 0.1× 155 3.1k
Werner Maier Germany 25 279 0.6× 121 0.3× 647 3.4× 29 0.2× 36 0.2× 110 2.2k
Saroj Jayasinghe Sri Lanka 20 210 0.5× 34 0.1× 256 1.4× 65 0.4× 9 0.1× 114 1.5k
Marcel F. Jonker Netherlands 18 776 1.8× 43 0.1× 386 2.0× 20 0.1× 8 0.1× 44 1.5k
Ricardo Ocaña‐Riola Spain 21 293 0.7× 28 0.1× 307 1.6× 18 0.1× 19 0.1× 67 1.3k
Hsien-Ho Lin Taiwan 32 268 0.6× 22 0.1× 233 1.2× 53 0.3× 14 0.1× 97 4.1k
Anna Mölter United Kingdom 19 148 0.3× 126 0.3× 102 0.5× 3 0.0× 101 0.6× 33 1.1k
Jinjun Ran China 23 551 1.3× 69 0.2× 136 0.7× 11 0.1× 4 0.0× 99 3.1k
Weibing Wang China 29 221 0.5× 22 0.1× 273 1.4× 102 0.6× 5 0.0× 156 2.9k

Countries citing papers authored by Xiaodong Guan

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Guan more than expected).

Fields of papers citing papers by Xiaodong Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Guan. The network helps show where Xiaodong Guan may publish in the future.

Co-authorship network of co-authors of Xiaodong Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Guan. A scholar is included among the top collaborators of Xiaodong Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Guan. Xiaodong Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Shujie, Tiansheng Wang, Jingkai Wei, et al.. (2025). Statin Use and Risk of Intracerebral Hemorrhage in Chinese Population. Neurology. 104(8). e213489–e213489. 1 indexed citations
2.
Zhang, Yichen, Luwen Shi, Huseyin Naci, et al.. (2025). Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis. The Lancet Oncology. 26(9). 1252–1260. 2 indexed citations
3.
Bai, Lin, et al.. (2025). Medicine availability and affordability for paediatric cancers, China. Bulletin of the World Health Organization. 103(1). 19–31B.
4.
5.
Guan, Xiaodong & Donggen Wang. (2024). Examining the roles of transport captivity and travel dissonance in travel satisfaction. Transportation Research Part A Policy and Practice. 182. 104023–104023. 7 indexed citations
6.
Wang, Tiansheng, Til Stürmer‎, Shujie Dong, et al.. (2024). The Effect of Sodium Glucose Cotransporter‐2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis. Pharmacoepidemiology and Drug Safety. 33(8). e5876–e5876. 1 indexed citations
7.
8.
Zhang, Yi, Lan Zhang, Yichen Zhang, et al.. (2024). Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysis. EClinicalMedicine. 71. 102561–102561. 12 indexed citations
9.
An, Zihao, Caroline Mullen, Xiaodong Guan, Dick Ettema, & Eva Heinen. (2024). Shared micromobility, perceived accessibility, and social capital. Transportation. 53(2). 1025–1060. 3 indexed citations
10.
11.
Ma, Zhuo, Man Xu, Tao Huang, et al.. (2024). Association of potentially inappropriate medications with prognosis among older patients with non-small cell lung cancer. BMC Geriatrics. 24(1). 550–550. 1 indexed citations
12.
Shi, Luwen, et al.. (2024). Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005–2020: an observational study. The Lancet Regional Health - Western Pacific. 46. 101077–101077. 1 indexed citations
13.
14.
Guan, Xiaodong, Meng Zhou, & Donggen Wang. (2023). Reference points in travel satisfaction: Travel preference, travel experience, or peers’ travel?. Transportation Research Part D Transport and Environment. 124. 103929–103929. 11 indexed citations
15.
16.
Hu, Lin, et al.. (2022). The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China. Frontiers in Public Health. 10. 936719–936719. 9 indexed citations
17.
18.
Hu, Hao, Xiaodong Guan, Carolina Oi Lam Ung, et al.. (2018). Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease. Chinese Medicine. 13(1). 28–28. 14 indexed citations
19.
Guan, Xiaodong, et al.. (2018). Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China. BMJ Open. 8(7). e022328–e022328. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seyed Saeed Hashemi Nazari Breakdown of academic impact, for papers by Ming Wu Breakdown of academic impact, for papers by Werner Maier Breakdown of academic impact, for papers by Saroj Jayasinghe Breakdown of academic impact, for papers by Marcel F. Jonker Breakdown of academic impact, for papers by Ricardo Ocaña‐Riola Breakdown of academic impact, for papers by Hsien-Ho Lin Breakdown of academic impact, for papers by Anna Mölter Breakdown of academic impact, for papers by Jinjun Ran Breakdown of academic impact, for papers by Weibing Wang
Rankless by CCL
2026